PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
Basic information |
| Metabolite name | PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
 | HMDB0005780 |
 |
C00350 |
 |
5283497 |
| Synonyms | PE(O-16:1(1Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
| HMDB0005780 |
|
C00350 |
|
5283497 |
| Synonyms | PE(O-16:1(1Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
| No. of studies | 2 |
|
Relationship between PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M609 | Type2 | LPS + NBP group vs. LPS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M687 | Type1 | depression group vs. control group | Serum | Human | Down |